financetom
Business
financetom
/
Business
/
Bandhan Bank Q2 profit down 5% at Rs 920 cr
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bandhan Bank Q2 profit down 5% at Rs 920 cr
Nov 2, 2020 6:16 AM

Bandhan Bank on Monday reported 5.3 percent decline in net profit at Rs 920 crore for September quarter of the current fiscal year. The bank clocked a net profit of Rs 971.80 crore in the same period of 2019-20.

Total income grew 22 percent to Rs 2,304.90 crore in July-September 2020-21 as against Rs 1,889.30 crore in the year-ago period, Bandhan Bank said in a regulatory filing. Net interest income of the Kolkata-headquartered lender jumped 25.8 percent to Rs 1,923.1 crore during the quarter while the non-interest income grew 6.1 percent to Rs 381.8 crore.

Bandhan Bank said it has reported the highest ever quarterly profit before tax at Rs 1,233 crore during the period under review. Net Interest Margin (annualised) in the quarter fell to 8 percent against 8.2 percent in year-ago period. During the quarter, the bank took accelerated additional provision on standard advances amounting to Rs 300 crore. With this provision and the additional standard assets provision that bank is carrying in micro banking portfolio, the total additional provision in books stands at Rs 2,096 crore, it said.

The bank’s gross non-performing assets fell to 1.2 percent (Rs 874 crore) of gross advances as of September 30, 2020 as against 1.8 percent (Rs 1,064.20 crore) by the year-ago same period. Net NPAs too improved to 0.4 percent (Rs 262.50 crore) from 0.6 percent (Rs 336.90 crore).

”As the moratorium ended on 31st August 2020 coupled with robust rural performance, we have seen an all-round improvement in collection, disbursement and deposits. On deposits front, we have witnessed the best ever quarter whereas on the disbursement front, we are close to pre-COVID-19 level.”

Collections have seen a steady improvement month-on-month and is expected to reach near normal in the next 90 days. We now look forward to accelerate the business in H2FY 21,” Managing Director and CEO Chandra Shekhar Ghosh said. Total Advances grew 19.4 percent to Rs 76,614.6 crore as on September 30, 2020. Total deposits increased 34.4 percent to Rs 66,127.7 crore.

Bandhan Bank stock was trading at Rs 305.50 on BSE, up 5.62 percent from the previous close.

First Published:Nov 2, 2020 3:16 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CSL gets $121 mln contract to increase US stockpile for bird flu vaccines to 40 mln doses
CSL gets $121 mln contract to increase US stockpile for bird flu vaccines to 40 mln doses
Oct 3, 2024
Sept 25 (Reuters) - Australia's CSL said on Wednesday it has got a contract from the U.S. Department of Health and Human Services (HHS) worth $121.4 million to increase the U.S. government's stockpile for bird flu vaccines to 40 million doses. Under the multi-year contract CSL will deliver its MF59 adjuvant, an ingredient that can be used to manufacture vaccines...
--American Outdoor Brands Gets Board Authorization for $10 Million Share Repurchase Program Ending Sept. 30 Next Year
--American Outdoor Brands Gets Board Authorization for $10 Million Share Repurchase Program Ending Sept. 30 Next Year
Oct 3, 2024
05:50 PM EDT, 09/25/2024 (MT Newswires) -- Price: 9.01, Change: +0.32, Percent Change: +3.68 ...
Telesis Bio, Beckman Coulter Form Partnership on DNA Synthesis Tech -- Shares Rise After Hours
Telesis Bio, Beckman Coulter Form Partnership on DNA Synthesis Tech -- Shares Rise After Hours
Oct 3, 2024
05:57 PM EDT, 09/25/2024 (MT Newswires) -- Telesis Bio ( TBIO ) said late Wednesday it formed a partnership with Beckman Coulter Life Sciences to create scalable biofoundries, with the goal of delivering solutions for sustainable and rapid on-premise DNA synthesis. The partnership provides an open solution to the market, allowing the incorporation of constructs from other providers compatible with...
Concentrix Fiscal Q3 Earnings, Revenue Rise; FY EPS Guidance Cut; Shares Fall After Hours
Concentrix Fiscal Q3 Earnings, Revenue Rise; FY EPS Guidance Cut; Shares Fall After Hours
Oct 3, 2024
05:49 PM EDT, 09/25/2024 (MT Newswires) -- Concentrix ( CNXC ) reported fiscal Q3 non-GAAP earnings Wednesday of $2.87 per diluted share, up from $2.76 a year earlier. Four analysts polled by Capital IQ expected $2.93. Sales for the quarter ended Aug. 31 rose to $2.39 billion from $1.63 billion a year earlier. Four analysts surveyed by Capital IQ expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved